Posted on 10/8/20
Sensei Biotherapeutics Announces $28.5 Million Financing
Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing personalized yet off the shelf immunotherapies for cancer and infectious diseases
Posted on 10/8/20
Christine Cormier Named Clinic Manager at Peak Physical Therapy & Sports Performance Norwell Clinic
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, recently . . .
Posted on 10/7/20
Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says
The head of the U.S. government's Operation Warp Speed COVID-19 vaccine program, Moncef Slaoui, said he expects phase 3 clinical trial data for multiple coronavirus vaccines . . .
Posted on 10/7/20
Acceleron Pharma Plan For Sotatercept Adds To Buy Conviction
SummaryAcceleron will start a Phase 3 sotatercept for PAH trial by year end.Q3 results should show continuing good Reblozyl revenue ramp.It is possible sotatercept will see . . .
Posted on 10/7/20
SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock
STAMFORD, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 10/7/20
C4 Therapeutics Closes IPO
WATERTOWN, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively . . .
Posted on 10/6/20
Talaris Therapeutics Closes $115 Million Series B Financing
Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune tolerance across
Posted on 10/6/20
Report: Moderna and Pfizer Vaccine Trial Participants Report Serious Side Effects
Three patients taking part in clinical trials for Moderna's (NASDAQ:MRNA) coronavirus vaccine candidate and two taking part in Pfizer's (NYSE:PFE) study have experienced intense side effects, . . .
Posted on 10/5/20
Applied BioMath Announces Two-Year Strategic Partnership with Xilio Therapeutics
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a two-year strategic . . .
Posted on 10/5/20
Vaxxas Announces $22M Award from U.S. Government
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced a $22 million United States government award to support the deployment of Vaxxas’ proprietary . . .
Posted on 10/5/20
Alivio Therapeutics Awarded $3.3 Million from U.S. Department of Defense
BOSTON--(BUSINESS WIRE)--Alivio Therapeutics, a biotechnology company developing an inflammation-targeting disease immunomodulation platform for the potential treatment of chronic and acute inflammatory disorders, today announced a $3.3 . . .
Posted on 10/5/20
What If Pfizer's and Moderna's Coronavirus Vaccine Results Are Delayed?
The countdown is on -- and I'm not referring to the U.S. elections. Many Americans anxiously await the results from the first round of coronavirus vaccines . . .
Posted on 10/5/20
Is Now a Good Time to Buy Moderna Stock?
Moderna's (NASDAQ:MRNA) stock has cooled off in recent weeks; currently at about $70, it's nowhere near the highs of more than $95 that it reached in . . .
Posted on 10/5/20
Where Will Vertex Pharmaceuticals Be in 5 Years?
Vertex Pharmaceuticals (NASDAQ:VRTX) is the blueprint for a growing pharmaceutical stock. Since it went public in 1991, the company has consistently increased revenue, recording annual revenue . . .
Posted on 10/4/20
Oncorus Prices IPO
CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Oncorus, Inc., a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer . . .
Posted on 10/4/20
LogicBio Therapeutics Proposes Public Offering of Common Stock
LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted . . .
Posted on 10/1/20
Laborie Medical Technologies and Signet Healthcare Partners Close GI Supply Acquisition
Laborie Medical Technologies (LABORIE), a leading diagnostic and therapeutic medical technology company, in partnership with Signet Healthcare Partners, a growth equity firm specializing in healthcare investments, . . .
Posted on 10/1/20
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
LUXEMBOURG, ZUG, Switzerland and WALTHAM, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Covis Group S.à r.l. and AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that they . . .
Posted on 10/1/20
Repligen: A Niche Play On Biologics
SummaryRepligen is a investment on the overall growth of the most exciting portion of the biotech industry without exposure to the full risks of the of . . .
Posted on 10/1/20
Moderna Coronavirus Vaccine Won't Be Available Before Election Day, CEO Says
Dealing a blow to President Trump's hope to have a vaccine before Election Day, Moderna's (NASDAQ:MRNA) CEO said the company's coronavirus vaccine won't be ready by . . .
Posted on 9/30/20
Interview with Ted Quinn, CEO & Founder of Activate Care
Ted Quinn is the CEO and Co-founder of Activate Care, a digital health company helping everybody engaged in
Posted on 9/30/20
Biophytis Announces A € 10 Million Capital Increase Through Private Placement
Biophytis SA, a clinical-stage biotechnology company specialized in the development of drug candidates for the treatment of aged related diseases, including neuromuscular diseases, today announced a . . .
Posted on 9/30/20
Allena Pharmaceuticals Announces $25M Debt Financing Agreement with Pontifax Ventures
NEWTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to . . .
Posted on 9/30/20
CVS Guidance Raise And Fresh Discount: Reiterate Buy
SummaryMail orders reached 40%+ of pharmacy sales, growing 3%+ QoQ.Premiums declined sequentially, but will return to growth soon.Minute Clinic provides deep penetration into the urgent care . . .
Posted on 9/29/20
Aegle Therapeutics Completes $6.5M Series A
Aegle Therapeutics Corporation, a first-in-class biotechnology company developing extracellular vesicles as therapy, today announced the completion of a $6.5M Series A round of financing.
Boston
